28 July 2021Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor…Lukas Kane XPHY.C On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection….